Thank you for joining us to discuss LifeMD Inc fourth-quarter and full-year 2024 earnings results. Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer; and Marc Benathen, ...

Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...

LifeMD董事长兼首席执行官Justin Schreiber表示支持礼来公司让肥胖治疗更易获得的努力，并赞扬与Gifthealth的无缝整合为患者带来更好的体验。Schreiber强调LifeMD致力于以患者为中心、经济实惠且便捷的医疗保健服务，他认为这将使其体重管理项目能够帮助患者实现更健康的生活。

Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement to offer Eli Lilly's weight-loss drug ...

Reports Q4 revenue $64.3M, consensus $57.4M. “LifeMD (LFMD) had a great fourth quarter. We not only achieved record quarterly revenue and ...

Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 ...

Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...

Healthcare services companies LifeMD (NASDAQ:LFMD) and Teladoc Health (NYSE:TDOC) announced partnerships with Eli Lilly's ...

(Reuters) -Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement with Gifthealth, the pharmacy ...

to offer streamlined access of single-dose vials of Lilly’s prescription obesity treatment Zepbound® (tirzepatide) to eligible LifeMD patients. Integration with the LillyDirect® self-pay ...

LifeMD, a virtual primary care services provider, said it is integrating with Gifthealth which will make Lilly's single-dose vials of Zepbound accessible to the company's eligible patients.

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.